The 120 references in paper V. Dobronravov A., N. Dunaeva V., В. Добронравов А., Н. Дунаева В. (2008) “ПОРАЖЕНИЕ ПОЧЕК И ХРОНИЧЕСКИЙ ВИРУСНЫЙ ГЕПАТИТ С // RENAL DAMAGE AND CHRONIC HEPATITIS C VIRUS” / spz:neicon:nefr:y:2008:i:4:p:9-19

1
Лобзин ЮВ, Жданов КВ, Волжанин ВМ. Вирусные гепатиты. ИКФ «Фолиант», СПБ., 1999; 104
(check this in PDF content)
2
Seeff LB. Natural history of hepatitis C. Hepatology 1997; 26[Suppl 1]: 21S-28S
(check this in PDF content)
3
Harris HE, Ramsay ME, Andrews N, Eldridge KP. Clinical course of hepatitis C virus during the first decade of infection: cohort study. BMJ 2002; 324(7335): 450-453
(check this in PDF content)
4
Игнатова ТМ, Апросина ЗГ, Серов ВВ и др. Внепечё­ ночные проявления хронического вирусного гепатита С. Тер архив 1998; 11: 9-16
(check this in PDF content)
5
Бурневич Э, Лопаткина Т, Абдурахманов Д. Внепечё­ ночные проявления диффузных заболеваний печени. Врач 2001; 3: 26-29
(check this in PDF content)
6
Fisher ME, Rossini M, Simmons E et al. A women with chronic hepatitis C infection and nephrotic syndrome who developed multiple renal lesions after interferon alfa therapy. Am J of Kidney Dis 2004; 44(3): 567-573
(check this in PDF content)
7
Wong W, Denton M, Rennke HG, Lin J. Hepatitis C, proteinuria and renal insufficiency. Am J of Kidney Dis 2004; 44(5): 924-929
(check this in PDF content)
8
Choo QL, Kuo G, Weiner AJ et al. Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science 1989; 244(4902): 359-362
(check this in PDF content)
9
Pascual M, Perrin L, Giostra E, Schifferli J. Hepatitis C virus in patients with cryoglobulinaemia type II. J Infec Dis 1990; 162(2): 569-570
(check this in PDF content)
10
Bandt M, Ribard P, Meyer O et al. Type II IgM monoclonal cryoglobulinemia and hepatitis C virus infection. Clin Ex. Rheumatol 1991; 9(6): 659-660
(check this in PDF content)
11
Johnson RJ, Gretch DR, Yamabe H et al. Membranoproliferative glomerulonephritis associated witn hepatitis C virus infection. N Engl J Med 1993; 328(7): 465-470
(check this in PDF content)
12
Garcia-Valdecasas J, Bernal C, Garcia F et al. Epidemiology of hepatitis C virus infection in patient with renal disease. J Am Soc Nephrol 1994; 5(2): 186-192
(check this in PDF content)
13
Sabry AA, Sobh MA, Irving WL et al. A comprehensive study of the association between hepatitis C virus and glomerulopathy. Nephrol Dial Transplant 2002; 17(2): 239-245
(check this in PDF content)
14
Cosio FG, Roche Z, Agarwal A et al. Prevalence of hepatitis C in patients with idiopathic glomerulopathies in native and transplant kidneys. Am J of Kidney Dis 1996; 28(5): 752-758
(check this in PDF content)
15
Mahmoud IM, Elhabashi AF, Elsawy E et al. The impact of hepatitis C virus viremia on renal graft and patient survival: a 9-year prospective study. Am J of Kidney Dis 2004; 43(1): 131-139
(check this in PDF content)
16
Cruzado JM, Carrera M, Torras J, Grinyo JM. Hepatitis C virus infection and de novo glomerular lesions in renal allografts. Am J of Transplant 2001; 1(2): 171-178
(check this in PDF content)
17
Mazzaro C, Panarello G, Tesio F et al. Hepatitis C virus risk: hepatitis C virus related syndrome. J of Internal Med 2000; 247(5): 535-545
(check this in PDF content)
18
Kasuno K, Ono T, Matsumori A et al. Hepatitis C virusassociated tubulointerstitial injury. Am J of Kidney Dis 2003; 41(4): 767-775
(check this in PDF content)
19
Liangpunsakul S, Chalasani N. Relationship between hepatitis C and microalbuminuria: results from the NHANES III. Kidney Int 2005; 67(1): 285-290
(check this in PDF content)
20
TsuiJI, Vittinghoff E, Shlipak MG, O’Hare AM. Relationship between hepatitis C and chronic kidney disease: results from the Third National Health and Nutrition Examination Survey. J Am Soc Nephrol 2006; 17(4): 1168-1174
(check this in PDF content)
21
McGuire BM, Julian BA, Bynon JS et al. Brief communication: Glomerulonephritis in patients with hepatitis C cirrhosis undergoing liver transplantation. Ann Intern Med 2006; 144(10): 735-741
(check this in PDF content)
22
AraseY, Ikeda K, MurashimaN et al. Glomerulonephritis in autopsy cases with hepatitis C virus infection. Intern Med 1998; 37(10): 836-840
(check this in PDF content)
23
Gopalani A, Ahuja TS. Prevalence of glomerulopathies in autopsies of patients infected with the hepatitis C virus. Am J Med Sci 2001; 322(2): 57-60
(check this in PDF content)
24
Johnson RJ, Gretch DR, Couser WG et al. Hepatitis C virus-associated glomerulonephritis: effect of alpha-interferon therapy. Kidney Int 1994; 46: 1700 -1704
(check this in PDF content)
25
Alric L, Plaisier E, Thebault S et al. Influence of antiviral therapy in hepatitis C virus-associated cryoglobulinemic MPGN. Am J of Kidney Dis 2004; 43(4): 617-623
(check this in PDF content)
26
Rossi P, Bertani T, Baio P et al. Hepatitis C virus-related cryoglobulinemic glomerulonephritis: Long-term remission after antiviral therapy. Kidney Int 2003; 63(6): 2236 -2241
(check this in PDF content)
27
Misiani R, Bellavita P, Fenili D et al. Interferon alfa-2a therapy in cryoglobulinemia associated with hepatitis C virus. N Engl J Med 1994; 330(11): 751-756
(check this in PDF content)
28
Pouteil-Noble C, Maiza H, Dijoud F, MacGregor B. Glomerular disease associated with hepatitis C virus infection in native kidneys. Nephrol Dial Transplant 2000; 15[Suppl 8]: 28-33
(check this in PDF content)
29
Козловская ЛВ, Мухин НА, Гордовская НБ и др. Фак­ торы риска прогрессирования криоглобулинемического гломерулонефрита, связанного с вирусом гепатита С. Клин медицина 2001; 4: 32-35
(check this in PDF content)
30
Wintrobe M, Buell MV. Hyperproteinemia associated with multiple myeloma. With report of a case in which an extraordinary hyperproteinemia was associated with thrombosis of the retinal veins and symptoms suggesting Raynaud’s disease. Bulletin of the John Hopkins Hospital 1933; 52: 156­ 165
(check this in PDF content)
31
Saadoun D, Sellam J, Ghillani-Dalbin P et al. Increased risks of lymphoma and death among patients with non-hepatitis C virus-related mixed cryoglobulinemia. Arch Intern Med 2006; 166(19): 2101-2108
(check this in PDF content)
32
Trejo O, Ramos-Casals M, Lopez-Guillermo A et al. Hematologic malignancies in patients with cryoglobulinemia: association with autoimmune and chronic viral diseases. Semin Arthritis Rheum 2003; 33(1): 19-28
(check this in PDF content)
33
Rizos E, Dimos G, Liberopoulos EN et al. Cryoglobulinemic purpura in visceral leishmaniasis. Rheumatol Int 2005; 25(6): 469-471
(check this in PDF content)
34
Kosmas N, Kontos A, Panayiotakopoulos G et al. Decreased prevalence of mixed cryoglobulinemia in the HAART era among HIV-positive, HCV-negative patients. J Med Virol 2006; 78(10): 1257-1261
(check this in PDF content)
35
Scotto G, Cibelli DC, Saracino A et al. Cryoglobulinemia in subjects with HCV infection alone, HIV infection and HCV/ HIV coinfection. J of infection 2006; 52(4): 294-299
(check this in PDF content)
36
Mascia MT, Ferrari D, Campioli D et al. Non HCV- related mixed cryoglobulinemia. Digestive and liver disease 2007; 39[Suppl 1]: 61-64
(check this in PDF content)
37
Almirall J, Amengual MJ, LopezT et al. Type II essential mixed cryoglobulinemia and renal disease. Hepatitis C virus association. Nefrologia 2002; 22(6): 531-539
(check this in PDF content)
38
D’Amico G, Fornasieri A. Cryoglobulinemia. In: Brady HR, Wilcox CS, eds. Therapy in nephrology and hypertension: a companion to Brenner and Rector's The kidney, W.B.Saunders Company, USA, 1999; 125-129
(check this in PDF content)
39
Lerner V, Watson G. Studies of cryoglobulins. I. Unusual purpura associated with the presence of high concentration of cryoglobulin (cold precipitable serum globulin). Am J Med Sci 1947; 314: 410-415
(check this in PDF content)
40
Brouet JC, Clauvel JP, Danon F et al. Biological and clinical significance of crioglobulins: a report of 86 cases. Am J Med 1974; 57: 775-788
(check this in PDF content)
41
Константинова НА. Криоглобулины и патология. Медицина, М., 1999; 176
(check this in PDF content)
42
Mazzaro C, Pozzato G, Zorat F et al. Cryoglobulinaemic membranoproliferative glomerulonephritis and hepatitis C virus infection. Ital J Gastroenterol Hepatol 1999; 31(1): 54-55
(check this in PDF content)
43
Kondili LA, Chionne P, Costantino A et al. Infection rate and spontaneous seroreversion of anti-hepatitis C virus during the natural course of hepatitis C virus infection in the general population. Gut 2002; 50(5): 693-696
(check this in PDF content)
44
Bellentani S, Tiribelli C, Saccoccio G et al. Prevalence of chronic liver disease in the general population of northern Italy: the Dionysos study. Hepatology 1995; 20(6): 1442-1449
(check this in PDF content)
45
Lamprecht P, Gutzeit O, Csernok E et al. Prevalence of ANCA in mixed cryoglobulinemia and chrinic hepatitis C virus infection. Clin Exp Rheumatol 2003; 21(6[Suppl. 32]): 89-94
(check this in PDF content)
46
Иванова ИВ, Волчкова ЕВ, Аленов МН и др. Вовле­ чение почек в патологический процесс при HCV инфекции. Проблема инфекции в клинической медицине: мат. науч. конф., ВМедА, СПб. 2003; 138
(check this in PDF content)
47
Дунаева НВ, Неустроева ЮА, Тихомирова ТА и др. Распространённость и факторы риска развития криоглобу- линемии, ассоциированной с хроническим гепатитом С. Медицинская иммунология 2007; 9(6): 575-580
(check this in PDF content)
48
Lunel F, Musset L, Cacoub P et al. Cryoglobulinemia in chronic liver diseases: role of hepatitis C virus and liver damage. Gastroenterology 1994; 106(5): 1291-1300
(check this in PDF content)
49
Pawlotsky J-M, Ben Yahia M, Andre C et al. Immunological disorders in C virus chronic active hepatitis: a prospective case- control study. Hepatology 1994; 19(4): 841-848
(check this in PDF content)
50
Wong VS, Egner W, Elsey T et al. Incidence, character and clinical relevance of mixed cryoglobulinemia in patients with chronic hepatitis C virus infection. Clin Exp Immunol 1996; 104(1): 25-31
(check this in PDF content)
51
Schmidt W, Stapleton J, LaBrecque D et al. Hepatitis C virus (HCV) infection and cryoglobulinemia: analysis of whole blood and plasma HCV-RNA concentrations and correlation with liver histology. Hepatology 2000;31: 737-744
(check this in PDF content)
52
Agarwal N, Handa R, Acharya S et al. A study of autoimmune markers in hepatitis C infection. Indian J Med Res 2001; 113: 170-174
(check this in PDF content)
53
Hwang S-J, Chu C-W, Huang D-F et al. Genetic predispositions for the presence of cryoglobulinemia and serum autoantibodies in Chinese patients with chronic hepatitis C. Tissue Antigens 2002; 59(1): 31-37
(check this in PDF content)
54
Liakina V, Speiciene D, Irnius A et al. Prevalence of cryoglobulinemia in patients with chronic HCV infection. Med Sci Monitor 2002; 8(1): 31-36
(check this in PDF content)
55
Iagnocco A, Coari G, Mammarella M et al. Joint sonography in asymptomatic patients with HCV correlated hepatitis. Clin Exp Rheumatology 2004; 22(1): 43-48
(check this in PDF content)
56
Kayali Z, Buckwold VE, Zimmerman B, Schmidt WN. Hepatitis C, cryoglobulinemia, and cirrhosis: a meta-analysis. Hepatology 2002; 36(4): 978-985
(check this in PDF content)
57
Sutton B, Corper A, Bonagura V, Taussig M. The structure and origin of rheumatoid factors. Immunol Today 2000; 21(4): 177-183
(check this in PDF content)
58
Toubi E, Zuckerman E, Kessel A et al. IgA rheumatoid factor in patients with chronic HCV infection: prevalence and clinical correlations. Clin Exp Rheumatol 2003; 21(4): 524
(check this in PDF content)
59
Gorevic PD, Frangione B. Mixed cryoglobulinemia cross­ reactive idiotypes: implications for the relationsship of MC to rheumatic and lymphoproliferative disease. Semin Hematol 1991; 28(2): 79-94
(check this in PDF content)
60
Kronenberger B, Ruster B, Elez R et al. Interferon alfa down-regulates CD81 in patients with chronic hepatitis C. Hepatology 2001; 33(6): 1518-1526
(check this in PDF content)
61
Muratori L, Gibellini D, Lenzi M et al. Quantification of hepatitis C virus- infected peripheral blood mononuclear cells by in situ reverse transcriptase-polymerase chain reaction. Blood 1996; 88(7): 2768-2774
(check this in PDF content)
62
Agnello V. The etiology and pathophysiology of mixed cryoglobulinemia secondary to hepatitis C virus infection. Springer Semin Immunopathol 1997; 19(1): 111-129
(check this in PDF content)
63
Вишневская ТВ, Масалова ОВ, Альховский СВ и др. Выявление маркёров репликации вируса гепатита С в мо- нонуклеарных клетках периферической крови больных хро­ ническим гепатитом С. Медицинская иммунология 2008; 10(4-5): 397-404
(check this in PDF content)
64
Moldvay J, Deny P, Pol S et al. Detection of hepatitis C virus RNA in peripheral blood mononuclear cells of infected patients by in situ hybridization. Blood 1994; 83(1): 269-273
(check this in PDF content)
65
Morsica G, Tambussi G, Sitia G et al. Replication of hepatitis C virus in B lymphocytes (CD19+). Blood 1999; 94(3): 1138-1139
(check this in PDF content)
66
Ducoulombier D, Roque-Afonso A-M, Di Liberto G et al. Frequent compartmentalization of hepatitis C virus variants in circulating B cells and monocytes. Hepatology 2004; 39(3): 817-825
(check this in PDF content)
67
Mele A, Pulsoni A, Bianco E et al. Hepatitis C virus and B-cell non-Hodgkin lymphomas: an Italian multicenter case- control study. Blood 2003; 102(3): 996-999
(check this in PDF content)
68
McOmber Morton L, Engels E, Holford T et al. Hepatitis C virus and risk of non-Hodgkin lymphoma: a population-based case-control study among Connecticut women. Cancer Epidemiology Biomarkers & Prevention 2004; 13: 425-430
(check this in PDF content)
69
Sansonno D, De Vita S, Cornacchiulo V et al. Detection and distribution of hepatitis C virus-related ptoteins in lymph nodes of patients with type II mixed cryoglobulinemia and neoplastic non- neoplastic lymphoproliferation. Blood 1996; 88(12): 4638-4645
(check this in PDF content)
70
Ivanovski M, Silvestri F, Pozzato G et al. Somatic hypermutation, clonal diversity, and preferential expression of the VH 51p1/ VLkv325 immunoglobulin gene combination in hepatitis C virus - associated immunocytomas. Blood 1998; 91(7): 2433-2442
(check this in PDF content)
71
Kitay-Cohen Y, Amiel A, Hilzenrat N et al. Bcl-2 rearrangement in patients with chronic hepatitis C associated with essential mixed cryoglobulinemia type II. Blood 2000; 96(8): 2910-2912
(check this in PDF content)
72
Zignego AL, Giannelli F, Marrocchi ME et al. T(14;18) translocation in chronic hepatitis C virus infection. Hepatology 2000; 31(2): 474-479
(check this in PDF content)
73
Zignego A, Ferri C, Giannelli F et al. Prevalence of bcl- 2 rearrangement in patients with chronic hepatitis C virus- related mixed cryoglobulinemia with or without B-cell lymphomas. Ann Intern Med 2002; 137(7): 571-580
(check this in PDF content)
74
Giannelli F, Moscarella S, Giannini C et al. Effect of antiviral treatment in patients with chronic HCV infection and t(14;18) translocation. Blood 2003; 102(4): 1196-1201
(check this in PDF content)
75
Vassilopoulos D, Younossi ZM, Hadziyannis E et al. Study of host and virological factors of patients with chronic HCV infection and associated laboratory or clinical autoimmune manifestations. Clin Exp Rheumatol 2003; 21(6[Suppl. 32]): 101­ 111
(check this in PDF content)
76
Fornasieri A, DAmigo G. Type II mixed cryoglobulinaemia, hepatitis C virus infection, and glomerulonephritis. Nephrol Dial Transplant 1996; 11[Suppl. 4]: 25-30
(check this in PDF content)
77
Sansonno D, Gesualdo L, Manno C et al. Hepatitis C virus-related proteins in kidney tissue from hepatitis C virus- infected patients with cryoglobulinemic membranoproliferative glomerulonephritis. Hepatology 1997; 25(5): 1237-1244
(check this in PDF content)
78
Roccatello D, Fornasieri A, Giachino O et al. Multicenter study on hepatitis C virus-related cryoglobulinemic glomerulonephritis. Am J of Kidney Dis 2007; 49(1): 69-82
(check this in PDF content)
79
Rodriguez-Idgo E, Casqueiro M, Bartolome J et al. Hepatitis C virus RNA in kidney biopsies from infected patients with renal diseases. J of Viral Hepatitis 2000; 7(1): 23-29
(check this in PDF content)
80
Sansonno D, Lauletta G, Montrone M et al. Hepatitis C virus RNA and core protein in kidney glomerular and tubular structures isolated with laser capture microdissection. Clin Exp Immunol 2005; 140(3): 498-506
(check this in PDF content)
81
Andre P, Komurian-Pradel F, Deforges S et al. Characterization of low- and very-low-density hepatitis C virus RNA-containing particles. J of Virol 2002; 76(14): 6919-6928
(check this in PDF content)
82
Triyatni M, Saunier B, Maruvada P et al. Interaction of hepatitis C virus- like particles and cells: a model system for studying viral binding and entry. J of Virol 2002; 76(18): 9335­ 9344
(check this in PDF content)
83
Непомнящих ГИ, Айдагулова СВ, Непомнящих ДЛ и др. Иммуногистохимическое, молекулярно-биологическое и патоморфологическое исследование биоптатов печени при хроническом гепатите С. Бюлл эксперим биологии и медицины 2002; 134(9): 356-360
(check this in PDF content)
84
Pileri P, Uematsu Y Campagnoli S et al. Binding of hepatitis C virus to CD 81. Science 1998; 282(5390): 938-941
(check this in PDF content)
85
Petracca R, Falugi F, Galli G et al. Structure-function analysis of hepatitis C virus envelope-CD81 binding. J of Virol 2000; 74(10): 4824-4830
(check this in PDF content)
86
Wunschmann S, Medh JD, Klinzmann D et al. Characterization of hepatitis C virus (HCV) and HCV E2 interactions with CD81 and the low-density lipoprotein receptor. J of Virol 2000; 74(21): 10055-10062
(check this in PDF content)
87
Roccasecca RM, Ansuini H, Vitelli A et al. Binding of the hepatitis C virus E2 glycoprotein to CD81 is strain specific and is modulated by a complex interplay between hypervariable regions 1 and 2. J of Virol 2003; 77(3): 1856-1867
(check this in PDF content)
88
Zhang J, Randall G, Higginbottom A et al. CD81 is required for hepatitis C virus glycoprotein-mediated viral infection. J of Virol 2004; 78(3): 1448-1455
(check this in PDF content)
89
Saunier B, Triyatni M, Ulianich L et al. Role of the asialoglycoprotein receptor in binding and entry of hepatitis C virus structural proteins in cultured human hepatocytes. J of Virol 2003; 77(1): 546-559
(check this in PDF content)
90
Lozach P-Y Lortat-Jacob H, De Lacroix de Lavalette A. et al. DC-SIGN and L-SIGN are high affinity binding receptors for hepatitis C virus glycoprotein E2. J of Biol Chem 2003; 278(22): 20358-20366
(check this in PDF content)
91
Pohlmann S, Zhang J, Baribaud F et al. Hepatitis C virus glycoproteins interact with DC-SIGN and DC-SIGNR. J of Virol 2003; 77(7): 4070-4080
(check this in PDF content)
92
Ludwig IS, Lekkerkerker AN, Depla E et al. Hepatitis C virus targets DC-SIGN and L-SIGN to escape lysosomal degradation. J of Virol 2004; 78(15): 8322-8332
(check this in PDF content)
93
Feng ZH, Wang QC, Nie QH et al. DC-SIGN: binding receptor for HCV? World J Gastroenterol 2004; 10(7): 925-929
(check this in PDF content)
94
Scarselli E, Ansuini H, Cerino R et al. The human scavenger receptor class B type I is a novel candidate receptor for the hepatitis C virus. EMBO 2002; 21(19): 5017-5025
(check this in PDF content)
95
Bartosch B, Vitelli A, Granier C et al. Cell entry of hepatitis C virus requires a set of co-receptors that include the CD81 tetraspanin and the SR-B1 scavenger receptor. J of Biol Chem 2003; 278(43): 41624-41630
(check this in PDF content)
96
Barth H, Cerino R, Arcuri M et al. Scavenger receptor class B type I and hepatitis C virus infection of primary Tupaia hepatocytes. J of Virol 2005; 79(9): 5774-5785
(check this in PDF content)
97
Voisset C, Callens N, Blanchard E et al. High density lipoproteins facilitate hepatitis C virus entry through the scavenger receptor class B type I. J of Biol Chem 2005; 280(9): 7793-7799
(check this in PDF content)
98
Barth H, Schafer C, Adah MI et al. Cellular binding of hepatitis C virus envelope glycoprotein E2 requires cell surface heparan sulfate. J of Biol Chem 2003; 278(42): 41003-41012
(check this in PDF content)
99
Yeh C-T, Lai H-X Chen T-C et al. Identification of a hepatic factor capable of supporting hepatitis C virus replication in a nonpermissive cell line. J of Virol 2001; 75(22): 11017-11024
(check this in PDF content)
100
Koutsoudakis G, Herrmann E, Kallis S et al. The level of CD81 cell surface expression is a key determinant for productive entry of hepatitis C virus into host cells. J of Virol 2007; 81(2): 588-598
(check this in PDF content)
101
Lanford RE, Chaves D, Chisari FV, Sureau C. Lack of detection of negative-strand hepatitis C virus RNA in peripheral blood mononuclear cells and other extrahepatic tissues by the highly strand-specific rTth reverse transcriptase PCR. J of Virol 1995; 69(12): 8079-8083
(check this in PDF content)
102
Mellor J, Haydon G, Blair C et al. Low level or absent in vivo replication of hepatitis C virus and hepatitis G virus/ GB virus C in peripheral blood mononuclear cells. J of Gen Virol 1998; 79(4): 705-714
(check this in PDF content)
103
Flint M, Maidens C, Loomis-Price LD et al. Characterization of hepatitis C virus E2 glycoprotein interaction with a putative cellular receptor, CD81. J of Virol 1999; 73(8): 6235-6244
(check this in PDF content)
104
Ali S, Pellerin C, Lamarre D, Kukolj G. Hepatitis C virus subgenomic replicons in the human embryonic kidney 293 cell line. J of Virol 2004; 78(1): 491-501
(check this in PDF content)
105
Kato T, Date T, Miyamoto M et al. Nonhepatic cell lines HeLa and 293 support efficient replication of the hepatitis C virus genotype 2a subgenomic replicon. J of Virol 2005; 79(1): 592-596
(check this in PDF content)
106
Kato T, Furusaka A, Miyamoto M et al. Sequence analysis of hepatitis C virus isolated from a fulminant hepatitis patient. J of Med Virol 2001; 64(3): 334-339
(check this in PDF content)
107
Gremion C, Grabscheid B, Wolk B et al. Cytotoxic T lymphocytes derived from patients with chronic hepatitis C virus infection kill bystander cells via Fas-FasL interaction. J of Virol 2004; 78(4): 2152-2157
(check this in PDF content)
108
He Y, Nakao H, Tan S-L et al. Subversion of cell signaling pathways by hepatitis C virus nonstructural 5A protein via interaction with Grb2 and P85 phosphatidylinositol 3-kinase. J of Virol 2002; 76(18): 9207-9217
(check this in PDF content)
109
Reyes G. The nonstructural NS5A protein of hepatitis C virus: an expanding, multifunctional role in enhancing hepatitis C virus pathogenesis. J Biomedical Sci 2002; 9(3): 187-197
(check this in PDF content)
110
Bataller R, Paik YH, Lindquist JN et al. Hepatitis C virus core and nonstructural proteins induce fibrogenic effects in hepatic stellate cells. Gastroenterology 2004; 126(2): 529­ 540
(check this in PDF content)
111
Machida K, Tsukiyama-Kohara K, Seike E et al. Inhibition of cytochrome c release in Fas-mediated signaling pathway in transgenic mice indused to express hepatitis C viral proteins. J of Biol Chem 2001; 276(15): 12140-12146
(check this in PDF content)
112
Duesberg U, von dem Bussche A, Kirschning C et al. Cell activation by synthetic lipopeptides of the hepatitis C virus (HCV) core protein is mediated by toll like receptors (TLRs) 2 and 4. Immunol Lett 2002; 84(2): 89-95
(check this in PDF content)
113
Dolganiuc A, Oak S, Kodys K et al. Hepatitis C core and nonstructural 3 proteins trigger toll-like receptor 2- mediated pathways and inflammatory activation. Gastroenterology 2004; 127(5): 1513-1524
(check this in PDF content)
114
Wornle M, Schmid H, Banas B et al. Novel role of toll­ like receptor 3 in hepatitis C-associated glomerulonephritis. Am J of Pathology 2006; 168(2): 370-385
(check this in PDF content)
115
Naka K, Dansako H, Kobayashi N et al. Hepatitis C virus NS5B delays cell cycle progression by inducing interferon- beta via Toll-like receptor 3 signaling pathway without replicating viral genomes. Virology 2006; 346(2): 348-362
(check this in PDF content)
116
AgnelloV. Mixedcryoglobulinemia and other extrahepatic manifestation HCV infection. In: Liang TJ, Hoofnagle JH. eds Hepatitis C, Academic, San Diego, CA, 2000; 295-313
(check this in PDF content)
117
Чернецова ОВ, Лопаткина ТН, Попова ИВ и др. ^нд ром Шегрена при хроническом гепатите С: клиничес­ кие особенности и диагностика. Тер архив 2003; 4: 33-37
(check this in PDF content)
118
KoskinasJ, KilidireasC, Karandreas N et al. Severe hepatitis C virus-related cryoglobulinaemic sensory-motor polyneuropathy treated with pegylated interferon-a2b and ribavirin: clinical, laboratory and neurophysiological study. Liver Int 2007; 27(3): 414-420
(check this in PDF content)
119
Dalrymple LS, Koepsell T, Sampson J et al. Hepatitis C virus infection and the prevalence of renal insufficiency. Clin J Am Soc Nephrol 2007; 2: 715 - 721
(check this in PDF content)
120
Смирнов АВ, Добронравов ВА, Каюков ИГ. Кар- дио-ренальный континуум: патогенетические основы пре­ вентивной нефрологии. Нефрология 2005; 9(3): 7-15 Поступила в редакцию 16.09.2008 г. Принята в печать 22.10.2008 г.
(check this in PDF content)